Not all patients respond to all types of immunotherapies. So how can doctors identify which treatments have the best chance of working in a specific patient? How can they quickly zero in on the best options on a list of immunotherapies that grows longer every day?
Immunotherapy
Roswell Park Comprehensive Cancer Center researchers have made another step toward personalizing cancer treatment while reducing the toxicity of certain cancer drugs using simple, noninvasive blood tests.
Results from the CheckMate 214 clinical trial show that combined therapy with two immunotherapy drugs, nivolumab and ipilimumab, can be very effective in the treatment of renal cell carcinoma, the most common type of kidney cancer.
A new clinical trial open at Roswell Park Comprehensive Cancer Center is currently investigating whether beta blockers, which calm the body’s response to stress, can boost immunotherapy in patients with advanced melanoma.
Although most patients on immunotherapies experience few — if any — side effects related to treatment, serious side effects can occur. Find out which symptoms to watch for.
I have been battling cancer successfully for 11 years. Looking back at my first diagnosis — stage 2 breast cancer, at age 42 — I downplay it now, because what happened next was so tragic.